spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Boehringer Ingelheim 

 HSMN NewsFeed - 9 Jan 2023
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Dec 2022
NRx Pharmaceuticals Announces the Appointment of Carrie M. Carretta, PhD, APN-BC, AHN-BC, PMHNP, Senior Vice President of Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Sep 2022
AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI(R)) for the Treatment of Adults with Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 3 Jan 2022
Curis Adds Three New Executives to Management Team Strengthening Medical Affairs, Clinical Development and Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2021
Chemomab Therapeutics Names Donald R. Marvin Chief Financial Officer, Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2021
FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 Aug 2021
SKYRIZI(R) (risankizumab-rzaa) Now Available in the U.S. as a Single 150 mg Injection for Adults with Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 23 Jul 2021
ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
Biopharmaceuticals Radiology Licensing
 HSMN NewsFeed - 28 Jun 2021
Eisai Inc. Announces the Appointment of Dr. Andree Amelsberg as Vice President, U.S. Medical Affairs, Oncology Business Group
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 20 Apr 2021
Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 30 Oct 2020
Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2020
NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2020
Jardiance(R) meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 27 Apr 2020
Actym Therapeutics Raises $34 Million Series A
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 19 Dec 2019
Metabomed Completes a $12.5 Million Raise in Order to Advance Its Lead Program Into Clinical Studies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Jun 2019
Lannett Launches Aspirin And Extended-Release Dipyridamole Capsules
Biopharmaceuticals Generics
 HSMN NewsFeed - 20 May 2019
Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 14 May 2019
Boehringer Ingelheim announces resolution of Cyltezo(R) patent litigation
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 14 May 2019
AbbVie Resolves HUMIRA(R) (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim
Biopharmaceuticals Litigation Licensing
 HSMN NewsFeed - 27 Mar 2019
Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Mar 2019
AbbVie Announces First Regulatory Approval of SKYRIZI(TM) (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis and Psoriatic Arthritis in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Mar 2019
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Biopharmaceuticals FDA Regulatory
 HSMN NewsFeed - 1 Mar 2019
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI(TM)) for the Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 Feb 2019
Boehringer Ingelheim and Lilly announce the CAROLINA(R) cardiovascular outcome trial of Tradjenta(R) met its primary endpoint of non-inferiority compared with glimepiride
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 11 Oct 2018
FDA Approves Stiolto(R) Respimat(R) Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Oct 2018
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of Investigational New Drug Application to Evaluate Tedopi(R) in Combination with Nivolumab in Pancreatic Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Oct 2018
Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 3 Oct 2018
Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Sep 2018
AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Aug 2018
Boehringer Ingelheim Announces The Launch Of CENTRAGARD(TM) (eprinomectin and praziquantel transdermal solution), Innovative Internal Parasite Protection For Cats
Biopharmaceuticals Veterinary Product Launch
 HSMN NewsFeed - 6 Aug 2018
AOBiome Therapeutics Announces the Expansion of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2018
Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes With AI
Devices Neurology Venture Capital
 HSMN NewsFeed - 16 Feb 2018
Arena Pharmaceuticals Announces Changes to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2018
Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer's trials
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jan 2018
Boehringer Ingelheim Announces Paul Fonteyne to Retire at the end of 2018. Wolfgang Baiker Appointed U.S. President & CEO Effective March 1, 2018
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 4 Oct 2017
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
Devices Personnel
 HSMN NewsFeed - 4 Sep 2017
Eyevensys Appoints Dr Ronald R. Buggage as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 14 Jun 2017
Arena Pharmaceuticals Appoints Jennifer Jarrett to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2017
Xencor's Lead Drug Candidate, XmAb5871, Receives Orphan Drug Designation from FDA for Treatment of IgG4-Related Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Apr 2017
Xencor Appoints Kevin Gorman, Ph.D., to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2017
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2017
Eyevensys Appoints Leading Life Sciences Executive and Ophthalmology Expert Dr. Garth Cumberlidge as Chairman
Biopharmaceuticals Devices Ophthalmology Personnel
 HSMN NewsFeed - 16 Feb 2017
FDA Expands Approval of SPIRIVA(R) RESPIMAT(R) (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Nov 2016
Gamida Cell Names Julian Adams, Ph.D. New Chairman of the Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2016
Ardelyx Strengthens Executive Leadership with the Appointment of Reginald Seeto, MBBS, as Chief Operating Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 28 Sep 2016
Assembly Biosciences Announces Key Additions to Microbiome Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2016
Egalet Appoints Patrick Shea as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2016
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Sep 2016
New Data: STIOLTO(R) RESPIMAT(R) (tiotropium bromide+olodaterol) Inhalation Spray Significantly Improved Exercise Capacity in People with COPD
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 15 Aug 2016
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 13 Jul 2016
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 19 May 2016
Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH
Biopharmaceuticals Licensing Acquisitions
 HSMN NewsFeed - 18 Apr 2016
AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2016
Therabron Therapeutics Expands Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2016
Boehringer Ingelheim's Gilotrif(R) Demonstrated Superiority to Iressa(R) (Gefitinib) in Reducing the Risk of Disease Progression and Treatment Failure in First-Line Treatment of Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Nov 2015
CureVac raises $110 Million in a private placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Oct 2015
Recro Pharma Provides Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2015
Jardiance(R) Demonstrated Cardiovascular (CV) Risk Reduction in People with Type 2 Diabetes at High Risk for CV Events
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 20 Aug 2015
S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jul 2015
Xencor Appoints Yujiro S. Hata to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2015
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim (China) to Collaborate in Bringing PV-10 to Market in China
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 29 Jun 2015
Aerie Pharmaceuticals Elects Julie McHugh and Michael M. du Toit to the Company’s Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 24 Jun 2015
ViraTherapeutics Raises €3.6 Million in the First Closing of a Series A Financing Round to Advance its Novel Oncolytic Virus Platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 16 Oct 2014
FDA Approves Boehringer Ingelheim's OFEV(R) (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Sep 2014
Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Aug 2014
Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Aug 2014
FDA Approves Boehringer Ingelheim's Striverdi(R) Respimat(R) (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jul 2014
Pradaxa(R) (dabigatran etexilate) Now Available in the UK for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and Prevention of Recurrence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 May 2014
Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2014
Vansen Pharma Inc. appoints new President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Biopharmaceuticals Endocrinology Litigation
 HSMN NewsFeed - 20 Jan 2014
Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Association’s Journal, Circulation
Devices Interventional
 HSMN NewsFeed - 3 Jan 2014
Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2013
Amakem Appoints Jean Marie Stassen as Vice President, Research and Development
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 28 Aug 2013
FDA Accepts Boehringer Ingelheim's Supplemental New Drug Application for Use of Dabigatran Etexilate Mesylate in Deep Vein Thrombosis and Pulmonary Embolism
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jul 2013
Warp Drive Bio Appoints Co-Founder Gregory Verdine, Ph.D., to Chief Executive Officer; Expands Team with Two Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 10 Dec 2012
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Nov 2012
URGENT NOTICE -- DRUG RECALL: Boehringer Ingelheim Pharmaceuticals, Inc. Initiates a Voluntary Recall of a Single Manufacturing Lot of Pradaxa(R) (dabigatran etexilate mesylate) Capsules 75mg in the U.S. and Puerto Rico
Biopharmaceuticals Cardiology Product Recall
 HSMN NewsFeed - 25 Sep 2012
Boehringer Ingelheim Expands Sales Force -- Adds 75 New Positions
Biopharmaceuticals Distribution
 HSMN NewsFeed - 4 Jun 2012
Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Mar 2012
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2012
Versant Ventures -- Leading Seed/Early Stage Healthcare Venture Capital Firm -- Appoints Dr. Guido Magni as Venture Partner
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 Mar 2012
S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2012
Amgen to Acquire Micromet
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 17 Jan 2012
Aerocrine appoints pulmonologist Paul Dorinsky, M.D., as medical director, North America
Devices Personnel
 HSMN NewsFeed - 22 Dec 2011
Covis Pharma to Acquire U.S. Rights from GlaxoSmithKline for Fortaz(R), Zinacef(R), Lanoxin(R), Parnate(R), and Zantac(R) Injection
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Dec 2011
Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Oct 2011
S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Oct 2011
FDA Approves Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Sep 2011
Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2011
Boehringer Ingelheim to Launch RE-ALIGN Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2011
Micromet Appoints Ulrich Grau, Ph.D. Executive Vice President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 May 2011
Lilly Provides Its Perspective in Response to Amylin Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 16 May 2011
Amylin Pharmaceuticals Files Suit Against Eli Lilly
Biopharmaceuticals Litigation
 HSMN NewsFeed - 16 Feb 2011
Savient Pharmaceuticals Announces Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 13 Jan 2011
Anders Lundström to Be the New CEO of Orexo
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2011
Lilly and Boehringer Ingelheim Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Jan 2011
Optimer Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2010
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
Devices Personnel
 HSMN NewsFeed - 20 Oct 2010
FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Neurology FDA
 HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Oct 2010
Exelixis Licenses Programs to Bristol-Myers Squibb Company
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Aug 2010
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2010
Sun Pharma Announces USFDA Approval for Generic Flomax(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Jun 2010
Exelixis Regains Full Rights to Develop and Commercialize XL184
Biopharmaceuticals
 HSMN NewsFeed - 26 May 2010
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2010
Teva Announces Launch of Generic Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 28 Apr 2010
Mylan Receives Approval for Generic Version of Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 19 Apr 2010
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Apr 2010
FDA Maintains Essential Use Status of Combivent(R) (ipratropium bromide and albuterol sulfate) Inhalation Aerosol Through 2013
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Mar 2010
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 2 Mar 2010
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX(R) 0.4mg Capsules and Immediately Commences Shipment
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 22 Feb 2010
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Feb 2010
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2010
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Dec 2009
Anika Therapeutics Acquires Fidia Advanced Biopolymers: A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2009
FDA Approves SPIRIVA(R) HandiHaler(R) for the Reduction of COPD Exacerbations
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 7 Dec 2009
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2009
Anika Therapeutics Receives European CE Mark Approval for "ELEVESS Light"
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 16 Nov 2009
Watson Names Robert A. Stewart Senior Vice President, Global Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 14 Oct 2009
Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2009
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 29 Sep 2009
Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 18 Aug 2009
Par Pharmaceutical & Aveva Drug Delivery Systems Receive Final Approval to Market Generic Catapres TTS(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jul 2009
Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2009
Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
Devices Dermatology
 HSMN NewsFeed - 26 May 2009
Anika Therapeutics Appoints Frank J. Luppino as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2009
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
Biopharmaceuticals
 HSMN NewsFeed - 28 Apr 2009
Eurand Appoints Dr. Robert Becker as Chief Research Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2009
Boehringer Ingelheim Plans to Launch U.S. Registry to Assess the State of Anticoagulation Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Mar 2009
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Mar 2009
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Feb 2009
Break-through Drug for Heart Failure in Dogs Now Available in the United States
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Jan 2009
Axikin Pharmaceuticals Spins out of Actimis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jan 2009
Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2008
Abstral receives marketing approval in Germany
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Dec 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Biopharmaceuticals
 HSMN NewsFeed - 10 Dec 2008
MorphoSys Appoints Dr. Arndt Schottelius as Chief Development Officer and Member of the Management Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
Biopharmaceuticals
 HSMN NewsFeed - 25 Sep 2008
Recent Research Shows Significant Benefits in Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Sep 2008
Nice Approves Pradaxa(R)*(Dabigatran Etexilate) - First New Oral Anticoagulant in the UK for Over 50 Years
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Sep 2008
Anika Therapeutics Announces Exclusive Latin America Distribution Agreement for ORTHOVISC Products with DePuy Mitek
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Aug 2008
NewCardio Names Ihor Gussak, M.D., Ph.D., FACC Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Jul 2008
Roxane Laboratories, Inc. Initiates a Nationwide Voluntary Recall of Two Manufacturing Lots of Sodium Polystyrene Sulfonate Suspension in the US and Puerto Rico
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 8 Jul 2008
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
Devices Dermatology Distribution
 HSMN NewsFeed - 30 Jun 2008
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
Devices Orthopaedic
 HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Jun 2008
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Jun 2008
New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2008
Orexo Strengthens the Executive Management Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2008
Lannett Company Receives Approval for Dipyridamole Tablets USP, 25 mg, 50 mg, and 75 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Apr 2008
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
Devices Personnel
 HSMN NewsFeed - 17 Apr 2008
New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2008
Landmark Trial ONTARGET(R) Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population. From ONTARGET(R) it May be Concluded That Telmisartan can Prevent Every 5th Serious Cardiovascular Event
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Mar 2008
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Mar 2008
Icagen Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2008
Orexo: Rapinyl(TM) has Received Swedish Marketing Authorization
Biopharmaceuticals Regulatory Drug Delivery
 HSMN NewsFeed - 19 Feb 2008
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Feb 2008
Anika Therapeutics Launches ORTHOVISC(R) mini in Europe
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 31 Jan 2008
Teva Announces Tentative Approval of Generic Flomax(R) Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 29 Jan 2008
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2008
Knopp Neurosciences Completes First Series B Financing of $10 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Dec 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Dec 2007
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2007
Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 20 Nov 2007
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 20 Nov 2007
Ranbaxy Launches Ran(R)-Tamsulosin Hydrochloride Capsules in Canada
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 8 Nov 2007
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Nov 2007
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 30 Oct 2007
Barr Receives Tentative Approval for a Generic Version of Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg and 1.5mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Oct 2007
Altus Pharmaceuticals Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2007
Xencor Expands Series E Financing to $60 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Oct 2007
Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2007
Medarex Announces the Appointment of Ursula B. Bartels as Senior Vice President, General Counsel and Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2007
Evotec to Acquire Renovis, Seek NASDAQ Listing
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2007
Anika Therapeutics Promotes Randall Wilhoite to Vice President-Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Anika Therapeutics Receives FDA Approval for ELEVESS(TM) Product
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 12 Jul 2007
Barr Confirms Patent Challenge of Aggrenox(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 11 Jul 2007
Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2007
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 5 Jul 2007
New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 22 Jun 2007
Ranbaxy Receives Tentative Approval for Tamsulosin Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Jun 2007
NanoMed Pharmaceuticals Hires Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2007
Boehringer Ingelheim Initiates SPRING Study of Aptivus(R) (tipranavir) capsules in Diverse Group of Highly Treatment-Experienced HIV Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 6 Jun 2007
Lewis T. 'Rusty' Williams, M.D., Ph.D. Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2007
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
Biopharmaceuticals Urology
 HSMN NewsFeed - 2 May 2007
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2007
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 16 Apr 2007
Ipsen Appoints Sean McKercher as Vice President of Commercial Development in North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2007
Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 22 Mar 2007
Bentley Announces Approval for Tamulosin in Spain
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 19 Mar 2007
Spectrum Pharmaceuticals Bolsters Ozarelix Team with Addition of In-House Urology Expert Bela S. Denes, MD, FACS
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 7 Feb 2007
Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2007
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
Biopharmaceuticals Urology
 HSMN NewsFeed - 11 Jan 2007
Lannett to Commence Marketing Meloxicam for Arthritis
Biopharmaceuticals Generics
 HSMN NewsFeed - 8 Jan 2007
Idenix Pharmaceuticals, Inc. Announces Appointment of Douglas Mayers, M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
ORTHOVISC(R) Clinical Study Commenced To Expand Usage
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 3 Jan 2007
Spectrum Pharmaceuticals Announces FDA's Acceptance of Ozarelix IND and Approval of Phase 2b Protocol in BPH (Benign Prostate Hypertrophy)
Biopharmaceuticals Urology
 HSMN NewsFeed - 26 Dec 2006
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 21 Dec 2006
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 15 Dec 2006
ORTHOVISC(R) Receives Unique Reimbursement Code
Biopharmaceuticals Orthopaedic Reimbursement
 HSMN NewsFeed - 13 Dec 2006
Vion Pharmaceuticals Enters Into Manufacturing Agreement for Cloretazine(R) (VNP40101M) With Ben Venue Laboratories
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2006
Positive Phase 3 Results for New Fixed Oral Dose Anticoagulant Presented at 48th Annual Meeting of the American Society of Hematology
Biopharmaceuticals
 HSMN NewsFeed - 27 Nov 2006
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Nov 2006
Anika Therapeutics Appoints Constance Garrison as Vice President of Regulatory and Clinical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2006
FDA Approves MIRAPEX for the Treatment of Moderate-to-Severe Primary Restless Legs Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2006
Panacos Appoints Scott McCallister, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2006
Boehringer Ingelheim Launches PROUD Study to Explore Possible Disease-Modifying Effect of Pramipexole
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Oct 2006
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Agreement to Acquire Zantac(R) from Johnson & Johnson and the Pfizer Consumer Healthcare Business
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 3 Oct 2006
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2006
Watson Names Thomas Russillo as President, U.S. Generics Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Aug 2006
Pramipexole Safe and Effective in Treating Restless Legs Syndrome, Study Shows
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Aug 2006
New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Aug 2006
Schering-Plough Appoints Trevor Juniper General Manager, Schering-Plough China
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2006
Teva Announces Final Approval of Meloxicam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Jul 2006
Par Pharmaceutical Receives Final Approval to Market Meloxicam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Jul 2006
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Jul 2006
Sykora Named StoneBridge Pharma President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2006
OXiGENE'S Board of Directors Names Experienced Biotech Executive, Richard Chin, M.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2006
Altus Pharmaceuticals Hires Dr. Burkhard Blank as Senior Vice President of Medicine, Regulatory Affairs and Project Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2006
MorphoSys and Schering-Plough Sign R&D Agreement
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2006
Astex Announces New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2006
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2006
Altus Pharmaceuticals Appoints Lauren Sabella Vice President, Commercial Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2006
Bedford Laboratories(TM) to Begin Shipping Mitoxantrone Injection USP
Biopharmaceuticals Generics
 HSMN NewsFeed - 5 Apr 2006
Pramipexole Significantly Improved Symptoms of Restless Legs Syndrome, New Studies Show
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Apr 2006
OccuLogix Expands Focus on Age-Related Eye Diseases
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 20 Mar 2006
Corautus Genetics Reports Fourth Quarter and 2005 Financial Results and Provides Update on Temporary Suspension of GENASIS Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 Mar 2006
Ventiv Health Expands Contract Sales Agreement with Boehringer Ingelheim
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2006
Roxane Laboratories, Inc. Resumes Shipments of Fluticasone Propionate Nasal Spray, 50 mcg
Biopharmaceuticals Generics
 HSMN NewsFeed - 27 Feb 2006
MedImmune Promotes Smullen to Senior Vice President, Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Feb 2006
Eli Lilly and Company and Boehringer Ingelheim Announce Changes to Their Contractual Agreements for Yentreve(R)/AriClaim(R)
Biopharmaceuticals
 HSMN NewsFeed - 12 Jan 2006
XOMA Announces Senior Management Appointments
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 131

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 131 additional stories matching:
Boehringer Ingelheim
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.